ZEPP vs. NUTX, BNGO, ICCM, RPHM, RBOT, CLGN, VHAQ, SRTS, AVRO, and XAIR
Should you be buying Zepp Health stock or one of its competitors? The main competitors of Zepp Health include Nutex Health (NUTX), Bionano Genomics (BNGO), IceCure Medical (ICCM), Reneo Pharmaceuticals (RPHM), Vicarious Surgical (RBOT), CollPlant Biotechnologies (CLGN), Viveon Health Acquisition (VHAQ), Sensus Healthcare (SRTS), AVROBIO (AVRO), and Beyond Air (XAIR).
Zepp Health (NYSE:ZEPP) and Nutex Health (NASDAQ:NUTX) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and community ranking.
Zepp Health presently has a consensus target price of $4.96, suggesting a potential upside of 500.78%. Nutex Health has a consensus target price of $15.00, suggesting a potential upside of 2,164.49%. Given Nutex Health's higher possible upside, analysts clearly believe Nutex Health is more favorable than Zepp Health.
52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Comparatively, 48.5% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Zepp Health has a net margin of -8.66% compared to Nutex Health's net margin of -18.49%. Zepp Health's return on equity of -8.55% beat Nutex Health's return on equity.
Nutex Health received 4 more outperform votes than Zepp Health when rated by MarketBeat users. Likewise, 100.00% of users gave Nutex Health an outperform vote while only 40.00% of users gave Zepp Health an outperform vote.
Zepp Health has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
In the previous week, Nutex Health had 5 more articles in the media than Zepp Health. MarketBeat recorded 6 mentions for Nutex Health and 1 mentions for Zepp Health. Zepp Health's average media sentiment score of 0.68 beat Nutex Health's score of -0.06 indicating that Zepp Health is being referred to more favorably in the media.
Zepp Health has higher revenue and earnings than Nutex Health. Zepp Health is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.
Summary
Zepp Health beats Nutex Health on 9 of the 16 factors compared between the two stocks.
Get Zepp Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZEPP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZEPP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zepp Health Competitors List
Related Companies and Tools
